Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. Monagheddu

Pet-Driven Radiotherapy in Patients With Low Risk Diffuse Large B-Cell Lymphoma (Dlbcl): The Dlcl10 Multicenter Phase 2 Trial by Fondazione Italiana Linfomi (Fil)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Related publications

The Elderly Project by the Fondazione Italiana Linfomi: A Prospective Comprehensive Geriatric Assessment (Cga) of 1353 Elderly Patients With Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma: A Phase II Multicenter Study of the Fondazione Italiana Linfomi

Haematologica
Hematology
2018English

Clinical Characteristics of Patients With Negative Interim-Pet and Positive Final Pet: Data From the Prospective Pet-Oriented Hd0801 Study by Fondazione Italiana Linfomi (Fil)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

BCL-2 Protein Frequency in Patients With High-Risk Diffuse Large B-Cell Lymphoma

Sao Paulo Medical Journal
Medicine
2010English

Outcome After Salvage Radiotherapy to FDG-Pet/Ct Avid Disease Post Chemotherapy in Advanced Stage Diffuse Large B-Cell Lymphoma (Dlbcl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Antiviral Therapy and Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) With Hepatitis C (Hcv)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Phase 2 Study of Parsaclisib (Incb050465) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (Dlbcl) (Citadel-202)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Prognostic Value of Baseline FDG Pet Parameters in High Risk Diffuse Large B-Cell Lymphoma Patients

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Global Pivotal Phase 2 Trial of the Cd19-Targeted Therapy Ctl019 in Adult Patients With Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (Dlbcl)-An Interim Analysis

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy